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Objective: To investigate the presence of different phytoconstituents in Mangifera
indica (M. indica) peel and evaluate its cytotoxicity to Artemia salina and hypoglycemic
potential in Swiss albino mice.
Methods: The methanolic extract of M. indica peel was used to determine the presence
of phytoconstituents. Brine shrimp lethality bioassay method was followed to determine
the cytotoxic potential of plant extract. In the case of hypoglycemic activity, oral
administration of extract at 200 and 400 mg/kg and standard glibenclamide at 10 mg/kg
was done, followed by determining the percentage of reduction of plasma glucose from
the initial level.
Results: The methanolic extract of M. indica peel showed the presence of ﬂavonoid,
saponin, steroid, tannins, terpenoids, glycosides and alkaloids. In brine shrimp lethality
bioassay, the LC50 of the extract and standard vincristine sulfate was found to be 2.04 and
0.41 mg/mL, respectively. After 90 and 150 min, the methanolic extract at 200 and
400 mg/kg showed prominent plasma glucose reduction of 13.95%, 22.48% and 14.16%,
26.18% respectively compared to standard glibenclamide showing 14.90% and 20.67%
plasma glucose reduction.
Conclusions: This current research afﬁrms prominent cytotoxic and moderate hypogly-
cemic potential of M. indica peel. Further bioactivity guided isolation of phytoconstituents
and investigation on higher animals can lead to development of new drug molecules.1. Introduction
As traditional medicine, the use of plant for the treatment of
different diseases has been going on since the dawn of human
history, owing to the presence of different phytoconstituents.
These phytoconstituents, also known as secondary metabolites,are a huge source of molecules with outstanding diversity which
helps to continue the drug discovery process [1].
Medicinal plants can exhibit different pharmacological ac-
tivities such as hypoglycemic activity and cytotoxicity. Brine
shrimp lethality bioassay is a technique to investigate the cyto-
toxic potential. This is based on cellular mechanism that may
occur via necrosis which is characterized by loss of membrane
integrity, death of cell or apoptosis, a genetic program of
controlled cell death [2]. Like other pharmacological activities,
the hypoglycemic activity is also exhibited by medicinal
plants, and glucose tolerance test is usually done for the
hypoglycemic activity. It is a therapeutic test where glucose is
given followed by testing the blood to determine the time it
takes to be cleared from the blood. The test is typically used
to test for diabetes, insulin resistance, reactive hypoglycemia
and rarer issue of starch digestion system.
Mangifera indica (M. indica) is a large spreading evergreen
tree which belongs to the family Anacardiaceae [3]. This plant isarticle under the CC BY-NC-ND license (http://
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as food, the different parts of this plant possess different
activities. For example, the bark is well known for its use in
the treatment of diarrhea; ripe fruit is used to treat habitual
constipation; the seeds are used as astringent to the bowels and
leaves are used to treat piles [3]. There have also been many
reported bioactivities like antioxidant, immunomodulatory, anti-
inﬂammatory, anti-allergic, antiviral, antibacterial, antifungal
and monoamine oxidase inhibitory activities of this plant [4]. In
this current research, the objectives were to prepare methanolic
extract of the peels of M. indica and analyze its cytotoxic and
hypoglycemic effects.
2. Materials and methods
2.1. Collection and identiﬁcation of M. indica
The entire plant ofM. indica along with its fruit was collected
from Dhaka, Bangladesh in March, 2015 and identiﬁed by the
taxonomist of the National Herbarium of Bangladesh, Mirpur,
Dhaka. The plant had been given an accession number of 41226
by the herbarium which can be used for further references.
2.2. Preparation of extract
After collecting the fruit of M. indica, the peel was separated
and sundried for about a week to convert it into powder by using
a grinder. For preparing methanolic extracts, the powder was
soaked in methanol in two separate jars. The jars were kept
closed with foil paper for seven days with occasional stirring.
Then the soaked peel was ﬁltered by cloth, cotton and Whatman
No. 1 ﬁlter paper. The ﬁltrate was dried in rotary evaporator at
50 C for 40 min. Then it was poured in a beaker and kept in the
fume hood for further evaporation of the solvent. After a week,
sticky extract was obtained, which was kept in a dry place at
normal temperature. The crude extract was used for phyto-
chemical and pharmacological evaluation.
2.3. Drugs and chemicals
The drugs glibenclamide (standard grade) and vincristine
sulfate were obtained from university laboratory. Tween 80 was
obtained from BDH Chemicals, UK. Normal saline solution was
purchased from Beximco Pharmaceuticals Ltd., Bangladesh.
Analytical reagent grade chemicals were used in all cases.
Dimethyl sulphoxide (DMSO) were obtained from university
laboratory.
2.4. Experimental animals
Swiss albino mice of either sex, weighed 25 g each, were
collected from the animal house of State University of
Bangladesh situated in Dhanmondi, Dhaka, Bangladesh. They
were housed in standard polypropylene cages and kept under
controlled conditions [room temperature of (24 ± 2) C, relative
humidity of 60%–70%]. Twenty mice were utilized to assess
hypoglycemic activity of M. indica. All experimental procedures
involving animals were conducted in accordance to ethical
guidelines of the Faculty of Biological Science, Dhaka University
(FBS/16/2016) and approved by the Institutional Ethical Com-
mittee of Faculty of Biological Science, University of Dhaka.2.5. Phytochemical screening
The methanolic extract of the peel of M. indica was taken as
the stock solution. This stock solution was then subjected to
successive standard tests for phytochemical identiﬁcation to ﬁnd
out the presence of different constituents including ﬂavonoids,
saponins, tannins, steroids, terpenoids, glycosides, alkaloids and
carbohydrates [5–11].
2.6. Brine shrimp lethality bioassay
The brine shrimp lethality bioasssay was performed according
to Mayer technique [12]. Shrimp nauplii were hatched in saline
solution which mimicked ocean water. Then 4 mg of each test
sample was taken and dissolved in 100 mL of pure DMSO in a
glass vial. Then 50 mL of this solution was taken in a test tube
containing 5 mL of simulated seawater. Thus the ﬁnal
concentration of the prepared solution in the ﬁrst test tube was
400 mg/mL. Then a series of solutions having concentrations of
200, 100, 50, 25, 12.5, 6.25, 3.125, 1.56, 0.781 mg/mL
respectively were prepared by serial dilution method. In the
case of negative control, the same protocol of dilution was
followed without adding the test sample.
A total of 2 mg vincristine sulfate was dissolved in DMSO to
prepare the positive control. Ten nauplii were added in each of the
test tubes. These test tubes were kept for 24 h after which the
number of survived nauplii was counted and percentage of mor-
tality was calculated. Then a graph of percentage of mortality v.s.
log values of concentrationwas drawn toﬁgure out theLC50values.
2.7. Evaluation of hypoglycemic activity
In this current study, the hypoglycemic effect of methanolic
extract of the peel of M. indica at 200 and 400 mg/kg was
analyzed. Twenty mice were randomly taken and divided into
four groups, each containing ﬁve mice. At ﬁrst, 10 g glucose,
dissolved in 100 mL water, was administered orally by means of
a long needle with a ball-shaped end to raise the blood glucose
level of the mice. The tail of each mouse was pricked and blood
was taken into the strip of diabetes measuring machine. Current
blood glucose level of every mouse was recorded which will be
used as baseline data. Then 0.2 mL extract at 200 and 400 mg/kg,
control (1% Tween 80 solution in saline) and the standard gli-
benclamide at 10 mg/kg were given orally. Blood glucose level
was checked after 0, 30, 90 and 150 min. The percentage
reduction of plasma glucose level was determined by the
following formula:
Percentage reduction of plasma glucose level =
a − b
a
× 100
where, a indicates initial plasma glucose level and b indicates
plasma glucose level at time ‘t’. The data was then recorded in a
chart to measure and compare the percentage reduction of
plasma glucose level between the standard and the sample.
3. Results
3.1. Phytochemical screening
The preliminary phytochemical screening of methanolic
extract of the peel of M. indica revealed the presence of
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and alkaloids.
3.2. Brine shrimp lethality bioassay
In the case of brine shrimp lethality bioassay, the methanolic
extract of peel ofM. indica showed prominent activity (Table 1).
After plotting the values of percentage of mortality against log
concentration, the LC50 value of this extract was found out to be
2.04 mg/mL. The standard vincristine sulfate showed LC50 value
of 0.41 mg/mL (Figure 1).Table 1
Cytotoxic effects of methanolic extract of M. indica peel.
Sample
concentration
(mg/mL)
Log
concentration
Percentage of
mortality
400 2.602 060 90
200 2.301 030 60
100 2.000 000 30
50 1.698 970 40
25 1.397 940 20
12.5 1.096 910 20
6.25 0.795 880 0
3.125 0.494 850 0
1.56 0.193 125 0
0.781 −0.107 350 0
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Figure 1. Percentage of mortality v.s. log concentration for methanolic
extract of M. indica peel.
Time (min)
STD ME 1 ME 2
Figure 2. Percentage reduction of plasma glucose level by test materials
and standard.
STD: Glibenclamide; ME 1: Methanolic extract of peel of M. indica at
200 mg/kg; ME 2: Methanolic extract of peel of M. indica at 400 mg/kg.3.3. Hypoglycemic activity
The effects of methanolic extract ofM. indica peel at 200 and
400 mg/kg on plasma glucose level were observed (Table 2) to
evaluate their hypoglycemic activity. The extract at 200 and
400 mg/kg showed signiﬁcant reduction of plasma glucose
comparable to standard glibenclamide after 90 and 150 min of
oral administration of sample and standard (Figure 2).Table 2
Plasma level of glucose of mice at different time (mmol/L).
Code No. 0 min 30 min
CTL 5.700 0 ± 0.141 4 10.660 0 ± 0.350 7
STD 4.160 0 ± 0.054 8*** 3.740 0 ± 0.114 0
ME 1 3.870 0 ± 0.941 8 9.440 0 ± 2.173 2
ME 2 4.660 0 ± 0.568 3 8.800 0 ± 2.941 1
Values are presented as mean ± SD (n = 5). ***: P < 0.001, **: P < 0.01, *:
normal saline); STD: Glibenclamide; ME 1: Methanolic extract of peel of M
400 mg/kg.4. Discussion
4.1. Brine shrimp lethality bioassay
We can see that vincristine sulfate which is an anticancer
drug has cytotoxic effect and the LC50 value was 0.41 mg/mL,
whereas the LC50 value of M. indica peel extract was 2.04 mg/
mL.
Due to the presence of different compounds in the extract, the
LC50 value is very prominent which represents its high cytotoxic
effect. There are some ﬂavonoids which were reported for their
strong anticancer properties. Furthermore, cholesterol lowering
and cytotoxic properties are attributed to the presence of sapo-
nins [13]. Steroids and alkaloids also have cytotoxic properties
[14]. Tannins possess anticancer property which is evident
from its inhibitory activity towards growth of MCF-7 breast
cancer cells [15]. Various types of terpenoids have the capability
to suppress the growth of cancer cells, and they are also found
efﬁcacious as anticancer agents in preclinical studies [16]. The
LC50 value of 2.04 mg/mL of the methanolic extract of
M. indica peel may be due to the presence of these secondary
metabolites. In order to conﬁrm whether this cytotoxic
activity is attributed to the presence of a single compound or
compounds, we have to further investigate the extract for
isolation of bioactive compounds and assess their cytotoxic
activity. Based upon this study, we can also identify lead
anticancer molecules having speciﬁc cytotoxicity toward
various cell lines.
4.2. Hypoglycemic effect
The methanolic extract showed dose dependent reduction of
plasma glucose level with time. This reduction is more90 min 150 min
7.340 0 ± 0.167 3 5.660 0 ± 0.207 4
*** 3.540 0 ± 0.151 6*** 3.300 0 ± 0.200 0***
3.330 0 ± 0.277 5*** 3.000 0 ± 0.538 5**
4.000 0 ± 1.081 7* 3.440 0 ± 1.031 0
P < 0.05 compared to control. CTL: Control (1% Tween 80 solution in
. indica at 200 mg/kg; ME 2: Methanolic extract of peel of M. indica at
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(22.48% and 26.18% reduction for methanolic extract of
M. indica peel at 200 and 400 mg/kg respectively after 150 min),
which is comparable to standard glibenclamide (20.67% after
150 min). So, it can be said that the extract was moderately
effective as hypoglycemic agent.
Phytoconstituents have got inherent capability to reduce the
plasma glucose at various phases. Flavonoids have been re-
ported to stimulate peripheral glucose uptake and express the
enzymes responsible for metabolism of carbohydrate [17].
Alkaloids are also hypoglycemic in nature [18]. Among many
enzymes, a-amylase is one which helps human body to
breakdown complex polysaccharides into oligosaccharides and
disaccharides. a-Glucosidase then hydrolyzes these into simple
absorbable monosaccharides which is responsible for increase
in postprandial glucose levels [19,20]. Tannins have a-amylase
and a-glucosidase inhibition capability [21]. Again, lupeol type
terpenoid is also reported for its a-amylase inhibition activity
[22]. Saponins can stimulate the beta cells and pancreatic islets
of the pancreas which can lead to the decrease in blood
glucose [23]. Stimulation of 5-adenosine monophosphate acti-
vated protein kinase and insulin receptor/insulin receptor sub-
strate 1/phosphatidylinositol 3-kinase/Akt signaling pathways
leading to decrease in blood glucose is also demonstrated by
saponin. So, saponins can also be another potential hypoglyce-
mic compound [24]. Isolation of the active phytoconstituents and
further evaluation of hypoglycemic activities can assert the
reason for showing hypoglycemic property. Besides, further
studies can be carried out to strengthen the glucose lowering
activity of peels of M. indica using streptozotocin- and aloxan-
induced diabetic rat models for chronic studies.
From the above discussion, it can be concluded that the
methanolic extract of the M. indica peel possesses prominent
cytotoxic and moderate hypoglycemic activity. The preliminary
screening of the extract and its pharmacological activity paves
the way towards discovering new drug molecules. Therefore,
further extensive studies on isolation of the phytoconstituents
and investigation on clinical level can lead to the development of
new therapeutic formulations.
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